DK1244808T3 - Fremgangsmåde til screening af multipel transformerede celler ved anvendelse af bicistronisk ekspression af fluorescerende proteiner - Google Patents

Fremgangsmåde til screening af multipel transformerede celler ved anvendelse af bicistronisk ekspression af fluorescerende proteiner

Info

Publication number
DK1244808T3
DK1244808T3 DK00977324T DK00977324T DK1244808T3 DK 1244808 T3 DK1244808 T3 DK 1244808T3 DK 00977324 T DK00977324 T DK 00977324T DK 00977324 T DK00977324 T DK 00977324T DK 1244808 T3 DK1244808 T3 DK 1244808T3
Authority
DK
Denmark
Prior art keywords
transformed cells
fluorescent proteins
bicistronic expression
different
screening multiple
Prior art date
Application number
DK00977324T
Other languages
English (en)
Inventor
Noelle-Anne Sunstrom
Peter Philip Gray
Robert D Gay
Original Assignee
Newsouth Innovations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newsouth Innovations Pty Ltd filed Critical Newsouth Innovations Pty Ltd
Application granted granted Critical
Publication of DK1244808T3 publication Critical patent/DK1244808T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
DK00977324T 1999-11-24 2000-11-24 Fremgangsmåde til screening af multipel transformerede celler ved anvendelse af bicistronisk ekspression af fluorescerende proteiner DK1244808T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ4223A AUPQ422399A0 (en) 1999-11-24 1999-11-24 Method of screening transformed or transfected cells
PCT/AU2000/001436 WO2001038557A1 (en) 1999-11-24 2000-11-24 Method of screening multiply transformed cells using bicistronic expression of fluorescent proteins

Publications (1)

Publication Number Publication Date
DK1244808T3 true DK1244808T3 (da) 2008-09-29

Family

ID=3818367

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00977324T DK1244808T3 (da) 1999-11-24 2000-11-24 Fremgangsmåde til screening af multipel transformerede celler ved anvendelse af bicistronisk ekspression af fluorescerende proteiner

Country Status (7)

Country Link
US (1) US7977097B1 (da)
EP (1) EP1244808B1 (da)
AT (1) ATE397089T1 (da)
AU (4) AUPQ422399A0 (da)
DE (1) DE60039072D1 (da)
DK (1) DK1244808T3 (da)
WO (1) WO2001038557A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL232477B1 (pl) 2001-09-20 2019-06-28 Immunex Corp System ekspresji gospodarza i sposób wytwarzania heteromerycznego kompleksu
WO2003083112A1 (fr) * 2002-04-01 2003-10-09 Japan Science And Technology Agency Population de cellules pourvues de codes d'identification et procedes pour le criblage de population de cellules
JP4870208B2 (ja) 2006-05-17 2012-02-08 エフ．ホフマン−ラ ロシュ アーゲー ポリペプチド産生細胞
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
AU2008309934B2 (en) 2007-10-12 2014-03-06 F. Hoffmann-La Roche Ag Protein expression from multiple nucleic acids
ES2442024T3 (es) 2008-07-15 2014-02-07 Academia Sinica Matrices de glucano sobre portaobjetos de vidrio revestidos con aluminio de tipo PTFE y métodos relacionados
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
US9914956B2 (en) 2012-08-18 2018-03-13 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
EP2700713B1 (en) 2012-08-21 2016-07-13 Miltenyi Biotec GmbH Screening and enrichment system for protein expression in eukaryotic cells using a tricistronic expression cassette
EP2888238A4 (en) 2012-08-21 2016-01-27 Academia Sinica BENZOCYCLO-OCTYNE COMPOUNDS AND USES THEREOF
CN103074346A (zh) * 2013-01-22 2013-05-01 山西大学 一种用于促通读药物筛选的有限细胞株的建立方法
EP3013365B1 (en) 2013-06-26 2019-06-05 Academia Sinica Rm2 antigens and use thereof
WO2014210564A1 (en) 2013-06-27 2014-12-31 Academia Sinica Glycan conjugates and use thereof
PT3613919T (pt) 2013-06-27 2023-02-13 Vaelinge Innovation Ab Painel de construção com um sistema de travamento mecânico
CA2923579C (en) 2013-09-06 2023-09-05 Academia Sinica Human inkt cell activation using glycolipids with altered glycosyl groups
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
AU2015206370A1 (en) 2014-01-16 2016-07-07 Academia Sinica Compositions and methods for treatment and detection of cancers
CN106415244B (zh) 2014-03-27 2020-04-24 中央研究院 反应性标记化合物及其用途
EP3149037A4 (en) 2014-05-27 2018-01-10 Academia Sinica Anti-her2 glycoantibodies and uses thereof
KR20230033737A (ko) 2014-05-27 2023-03-08 아카데미아 시니카 증진된 항체 효능을 위한 범용 당형태에 관한 조성물 및 방법
KR20220151036A (ko) 2014-05-27 2022-11-11 아카데미아 시니카 항-ｃｄ20 글리코항체 및 이의 용도
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
KR102494193B1 (ko) 2014-05-28 2023-01-31 아카데미아 시니카 항-ｔｎｆ-알파 글리코항체 및 이의 용도
WO2016040369A2 (en) 2014-09-08 2016-03-17 Academia Sinica HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
CA2972072A1 (en) 2015-01-24 2016-07-28 Academia Sinica Novel glycan conjugates and methods of use thereof
WO2016168848A1 (en) 2015-04-17 2016-10-20 University Of South Florida Animal model and method for studying gene-gene interactions
JP2019515876A (ja) 2016-03-08 2019-06-13 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ Ｎ−グリカンおよびそのアレイのモジュール合成のための方法
JP7213549B2 (ja) 2016-08-22 2023-01-27 シーエイチオー ファーマ インコーポレイテッド 抗体、結合性断片、および使用の方法
CN109790214B (zh) 2016-09-29 2022-09-06 豪夫迈·罗氏有限公司 用于选择产生多肽的细胞的改进方法
CR20190397A (es) 2017-03-10 2019-09-27 Hoffmann La Roche Método para producir anticuerpos multiespecíficos
CN110305900A (zh) * 2019-06-28 2019-10-08 大连大学 一种稳定表达vp1融合egfp的单克隆细胞株的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610034A (en) * 1987-04-29 1997-03-11 Alko Group Ltd. Immunoglobulin production by trichoderma
US5968738A (en) * 1995-12-06 1999-10-19 The Board Of Trustees Of The Leland Stanford Junior University Two-reporter FACS analysis of mammalian cells using green fluorescent proteins
EP0981633A2 (en) * 1997-02-13 2000-03-01 Memorial Sloan-Kettering Cancer Center Hybrid molecules for optically detecting changes in cellular microenvironments

Also Published As

Publication number Publication date
EP1244808A1 (en) 2002-10-02
AU1506001A (en) 2001-06-04
EP1244808A4 (en) 2004-05-12
AUPQ422399A0 (en) 1999-12-16
DE60039072D1 (de) 2008-07-10
WO2001038557A1 (en) 2001-05-31
ATE397089T1 (de) 2008-06-15
US7977097B1 (en) 2011-07-12
AU2009240859A1 (en) 2009-12-17
AU2006203524A1 (en) 2006-09-07
EP1244808B1 (en) 2008-05-28
AU2009240859B2 (en) 2012-05-17

Similar Documents

Publication Publication Date Title
DK1244808T3 (da) Fremgangsmåde til screening af multipel transformerede celler ved anvendelse af bicistronisk ekspression af fluorescerende proteiner
Edwalds-Gilbert et al. Regulation of poly (A) site use during mouse B-cell development involves a change in the binding of a general polyadenylation factor in a B-cell stage-specific manner
ATE269414T1 (de) Verfahren zur drogenuntersuchung
ATE211506T1 (de) Ein verfahren zum nachweis biologisch aktiver substanzen
DK1032705T3 (da) Probearrays og fremgangsmåder til at benytte probearrays til at skelne mellem DNA
ATE294391T1 (de) Methode mit hohem durchsatz
WO2000023621A3 (en) Visualization of rna in living cells
EP1721993A3 (en) Kits and methods for the detection of target nucleic acids with help of tag nucleic acids
EA199800566A1 (ru) Аденовирусный вектор (варианты), способ его получения, применение, репликационно-компетентное не содержащее аденовирус потомство, способ повышения размножения в комплементирующей клеточной линии аденовирусного вектора, способ генетической модификации клетки, композиция, клетка-хозяин, способ тестирования токсичности аденовирусного вектора, способ тестирования экспрессии чужеродного гена или гена-пассажира аденовирусного вектора
HK1090422A1 (en) A system for determining the electrical potential across a membrane
EP1170380A3 (en) Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
DE69131181D1 (de) Verfahren zum nachweis und zur quantifikation von zell-subsätzen innerhalb von subpopulationen einer vermischten zellpopulation
Godovac‐Zimmermann et al. Perspectives in spicing up proteomics with splicing
ATE304595T1 (de) Lichtproduzierender biosensor
EP1980573A3 (en) Isolated dendritic cell membrane protein genes
RU98112015A (ru) Скрининг-анализ соединений, стимулирующих продуцирование соматостатина и инсулина
US20030170744A1 (en) Multiplexed analysis of cellular responses using endogenous reporter genes
CN101550441B (zh) 含有生物标志物样本的高通量分析方法和样本库制备
WO1999047673A3 (en) Isolated mammalian membrane protein genes and related reagents
AU1695595A (en) Mammalian thymokine genes
BR9708256A (pt) Processo para identificar genes com expresão específica ao síto ou de síto preferido em células de marcacção específicas presentes em um ambiente de células diferente ou não daquele de sua origem e uso do mesmo
US8450066B2 (en) Methods for identifying the activity of gene products
EP1136568A4 (en) METHOD FOR DETERMINING NUCLEIC ACID
WO2004033648A3 (en) Isolated mammalian membrane protein genes; related reagents
FR2786787B1 (fr) Methode d'analyse in vitro d'un phenotype connu a partir d'un echantillon d'acides nucleiques